Journal
ONCOIMMUNOLOGY
Volume 4, Issue 3, Pages -Publisher
TAYLOR & FRANCIS INC
DOI: 10.4161/2162402X.2014.983761
Keywords
myeloid-derived suppressor cells; peptibody; tumor microenvironment; immunotherapy; immunosuppression
Categories
Ask authors/readers for more resources
Tumor-associated myeloid cells undermine the therapeutic efficacy of cancer immunotherapy by their inhibitory properties on immune effector cells. Development of therapeutic agents to deplete suppressive myeloid cells in tumor microenvironment requires identification of cell-specific targets. A competitive phage display technique on live cells paves the way to discovery of such a target.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available